Patrick Klein

Role: Halozyme, Inc.
Location: San Juan Capistrano, CA, US
LinkedIn followers: 500 followers

OtherView LinkedIn profile

Experience

Halozyme, Inc.
Present

Skills

Business Process
Vendor Management
Outsourcing
Business Process Improvement
IT Strategy
Business Strategy
Business Transformation
Portfolio Management
Mergers
Contract Negotiation
Strategic Planning
Asset Management
Cross-Functional Team Leadership
Commercial Real Estate
IT Service Management
Due Diligence
Change Management
Asset Managment
Executive Management
Operations Management
Mergers & Acquisitions
Business Analysis
Strategy
Budgets
Crm
Management
Project Management
Real Estate Development
Enterprise Software
Business Intelligence
Real Estate
Program Management
Corporate Real Estate
Pmo
Leadership
Location Intelligence
Customer Relationship Management (Crm)
Process Improvement
Business Development
Negotiation

Contact information

Verified work emails, personal emails, and direct dials — unlocked in one click.

Work email
•••••@halozyme.com
Personal email
•••••@•••••.com
Direct dial
+19•••••••50

Unlock verified contacts

Free to start · No credit card required

Current company

Halozyme, Inc.

Biotechnology Research · 538 employees · San Diego, California, United States

Halozyme is a biopharmaceutical company bringing disruptive solutions to significantly improve patient experiences and outcomes for emerging and established therapies. Halozyme advises and supports its biopharmaceutical partners in key aspects of new drug development with the goal of improving patients' lives while helping its partners achieve global commercial success. As the innovators of the ENHANZE® technology, which can reduce hours-long treatments to a matter of minutes, Halozyme's commercially-validated solution has positively impacted more than 400,000 patient lives via five commercialized products across more than 100 global markets. Halozyme and its world-class partners are currently advancing multiple therapeutic programs intended to deliver innovative therapies, with the potential to improve the lives of patients around the globe. Halozyme's proprietary enzyme rHuPH20 forms the basis of the ENHANZE® technology and is used to facilitate the delivery of injected drugs and fluids, potentially reducing the treatment burden of other drugs to patients. Halozyme has licensed its ENHANZE® technology to leading pharmaceutical and biotechnology companies including Roche, Baxalta, Pfizer, Janssen, AbbVie, Lilly, Bristol-Myers Squibb, Alexion and argenx. Halozyme derives revenues from these collaborations in the form of milestones and royalties as the company's partners make progress developing and commercializing their products being developed with ENHANZE®. We are a diverse team, who are committed to bringing therapies and results to patients. It's not enough to be qualified and experienced at what you do, we are looking for people who believe in our mission and match our values. We are building a company where people can pursue their career goals in a supportive and collaborative team environment. Visit www.halozyme.com/careers for more details. We are Halozyme.

halozyme.com

Find verified contacts for anyone on LinkedIn

Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.

Start for free See how it works

Free plan included · No credit card required

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.